SAGENOME

OhMyGene, a Molecular Diagnostic initiative of Sagenome Private Ltd, strives to provide reliable and innovative health care solutions for the wellbeing of humanity, utilizing genome-based technologies.

Through, state of the art lab facilities, top technical human resource, knowhow and knowledge base to analyse genetic variations of customers and with precise scientific data analysis, OhMyGene aims to provide robust, accurate and meaningful results of genetic predispositions. These DNA and related healthcare tests will provide significant information about important aspects of genetic health.

The FDA EMA approved genetic markers for clinical practise includes Cancer Management (tumour markers), Genetic health risks including susceptibility to Cancer, Heart disease Diabetes; Wellness Health traits, Personalized Nutrition Dietary factors, Fitness, Skin Hair care, Cellular ageing, Allergy, Sensitivity and Infertility management.

The Precision Health Care platform offered by OhMyGene, includes design and optimization of using genome profiles for health care, whether for disease diagnosis, intervention and/or prognosis.